In this study, new molecular fragments associated with genotoxic and nongenotoxic carcinogens are introduced to estimate the carcinogenic potential of compounds. Two rule-based carcinogenesis models were developed with the aid of SARpy: model R (from rodents' experimental data) and model E (from human carcinogenicity data). Structural alert extraction method of SARpy uses a completely automated and unbiased manner with statistical significance. The carcinogenicity models developed in this study are collections of carcinogenic potential fragments that were extracted from two carcinogenicity databases: the ANTARES carcinogenicity dataset with information from bioassay on rats and the combination of ISSCAN and CGX datasets, which take into acc...
The structure alerts (SA) for carcinogenicity/mutagenicity are a repository of the science on chemic...
111-122Carcinogenicity is one of the toxicological endpoints causing the highest concern. Also, the...
The EU FP6 project carcinoGENOMICS explored the combination of toxicogenomics and in vitro cell cult...
In this study, new molecular fragments associated with genotoxic and nongenotoxic carcinogens are in...
We assembled 390 chemicals with a structure non-alerting to DNA-reactivity (145 carcinogens and 245 ...
Carcinogenicity is an important toxicological endpoint that poses high concern to drug discovery. In...
Despite an overall decrease in incidence of and mortality from cancer, about 40% of Americans will b...
This paper describes my submission to one of the sub-problems formulated for the Predictive Toxicolo...
Carcinogenicity prediction is an important process that can be performed to cut down experimental co...
There is an increasing need for new reliable non-animal based methods to predict and test toxicity o...
The current gold-standard method for cancer safety assessment of drugs is a rodent two-year bioassay...
<div><p>The current gold-standard method for cancer safety assessment of drugs is a rodent two-year ...
<div><p>The current strategy for identifying the carcinogenicity of drugs involves the 2-year bioass...
For a database of 826 chemicals tested for carcinogenicity, we fragmented the structural formula of ...
<div><p>In the area of omics profiling in toxicology, i.e. toxicogenomics, characteristic molecular ...
The structure alerts (SA) for carcinogenicity/mutagenicity are a repository of the science on chemic...
111-122Carcinogenicity is one of the toxicological endpoints causing the highest concern. Also, the...
The EU FP6 project carcinoGENOMICS explored the combination of toxicogenomics and in vitro cell cult...
In this study, new molecular fragments associated with genotoxic and nongenotoxic carcinogens are in...
We assembled 390 chemicals with a structure non-alerting to DNA-reactivity (145 carcinogens and 245 ...
Carcinogenicity is an important toxicological endpoint that poses high concern to drug discovery. In...
Despite an overall decrease in incidence of and mortality from cancer, about 40% of Americans will b...
This paper describes my submission to one of the sub-problems formulated for the Predictive Toxicolo...
Carcinogenicity prediction is an important process that can be performed to cut down experimental co...
There is an increasing need for new reliable non-animal based methods to predict and test toxicity o...
The current gold-standard method for cancer safety assessment of drugs is a rodent two-year bioassay...
<div><p>The current gold-standard method for cancer safety assessment of drugs is a rodent two-year ...
<div><p>The current strategy for identifying the carcinogenicity of drugs involves the 2-year bioass...
For a database of 826 chemicals tested for carcinogenicity, we fragmented the structural formula of ...
<div><p>In the area of omics profiling in toxicology, i.e. toxicogenomics, characteristic molecular ...
The structure alerts (SA) for carcinogenicity/mutagenicity are a repository of the science on chemic...
111-122Carcinogenicity is one of the toxicological endpoints causing the highest concern. Also, the...
The EU FP6 project carcinoGENOMICS explored the combination of toxicogenomics and in vitro cell cult...